300086 康芝药业
2026/06 - 中期
人民币(K¥)
与去年末期
比较
2025/12
人民幣(K¥)
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)

非流动资产
长期股权投资0--0000
投资性房地产556,0700.00%556,070206,273226,007237,607
固定资产661,394-2.74%680,021992,215841,698890,943
在建工程16,096-10.60%18,00512,035145,62359,591
无形资产59,802-6.14%63,711139,858160,328167,552
商誉8,3000.00%8,30013,50020,05218,892
其他非流动资产151,670-5.45%160,419169,832170,606243,427
1,453,332-2.23%1,486,5261,533,7131,564,3141,618,012

流动资产
货币资金16,346-72.64%59,752113,185144,398269,812
应收账款29,642-19.38%36,76668,153103,82271,131
存货168,9655.53%160,117187,329236,429170,404
其他流动资产43,361-9.37%47,84374,11692,647159,113
258,315-15.16%304,479442,783577,297670,460

流动负债
短期借款174,3004.97%166,045171,085139,892133,218
应付票据0--0000
应付帐款65,02223.35%52,71366,25778,02157,401
其他流动负债327,847-10.11%364,733283,394163,829313,891
567,169-2.80%583,492520,736381,742504,511
流动资产净值(308,854)10.70%(279,013)(77,953)195,554165,949
资产总额减流动负债1,144,478-5.22%1,207,5131,455,7601,759,8691,783,961

非流动负债
长期借款153,575-15.53%181,820210,000324,978342,846
应付债券0--0000
其他非流动负债103,253-1.17%104,477104,85182,03685,607
256,828-10.29%286,297314,851407,014428,453

总权益
    实收股本455,1240.00%455,124455,124450,000450,000
    储备项目411,786-7.38%444,585660,388869,590866,183
股东权益866,910-3.65%899,7091,115,5121,319,5901,316,183
非控股权益20,739-3.57%21,50625,39733,26439,326